It's absurd to think that there is any standard co
Post# of 72440
As far as the money -- Alfasigma has the right of first negotiation. How can you expect to know what that negotiation will look like, at this stage of development?
If you're looking for linear, predictable timelines for a company's development, biotech is not a place you should be investing.